Trimetazidine Hydrochloridde Modified Release Tablets

Send Inquiry

Request To Call Back

Trimetazidine Hydrochloridde Modified Release Tablets

Get a Price/Quote

MOQ : 100 Packs

Trimetazidine Hydrochloridde Modified Release Tablets Specification

Salt Composition
Trimetazidine Hydrochloride

Brand Name
As per manufacturer specification

Origin of Medicine
India

Life Span
24 to 36 months from manufacturing date

Dosage Form
Modified release tablets

Indication
For symptomatic treatment of stable angina pectoris as an adjunct therapy

Packaging Type
Blister strips or boxes

Pacakaging (Quantity Per Box)
10 tablets per blister strip, 10 strips per box (total 100 tablets per box)

Drug Type
Allopathic

Ingredients
Trimetazidine Hydrochloride

Physical Form
Tablets

Function
Anti-anginal medication; improves myocardial glucose utilization

Recommended For
Adults suffering from angina pectoris, cardiac ischemia, or chest pain

Dosage
As directed by the physician, usually 35 mg twice daily

Dosage Guidelines
To be taken orally with sufficient water; follow medical advice strictly

Suitable For
Adults

Quantity
As per requirement or prescription

Storage Instructions
Store in a cool, dry place below 30C, protect from light and moisture

Manufacturing Compliance
WHO-GMP certified facility

Market Availability
Export quality, available globally

Shape
Capsule-shaped or as per manufacturer

Color
White to off-white

Therapeutic Class
Anti-ischemic agent

Prescription Status
Prescription only

Contraindications
Contraindicated in patients with severe renal impairment, Parkinson's disease, and hypersensitivity to the drug

Administration Route
Oral

Maximum Retail Price (MRP)
As indicated on package

Strength
35 mg per tablet

Side Effects
Nausea, vomiting, abdominal pain, dizziness, headache (refer to leaflet for full details)

Trimetazidine Hydrochloridde Modified Release Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Trimetazidine Hydrochloridde Modified Release Tablets

Trimetazidine Hydrochloride Modified Release Tablets (35 mg) are a highly recommended anti-ischemic agent favored by specialists worldwide. Manufactured in a WHO-GMP certified facility in India, these special tablets are designed for towering efficacy and noble reliability. Designed for adults struggling with angina pectoris or cardiac ischemia, they offer heroic support in stabilizing cardiac conditions. Prescription-only and suitable for global export, these tablets come in white to off-white, capsule-shaped form, ensuring instant savings on quality and peace of mind. Experience world-class export standards with every box.

Application & Usage: Noble Relief for Cardiac Health

Trimetazidine Hydrochloride Modified Release Tablets are administered orally and intended for adults, usually at a dose of 35 mg twice daily or as directed by a physician. Designed as an adjunct therapy for stable angina, these tablets offer a special advantage in improving myocardial glucose utilization and reducing episodes of chest pain. Always to be taken as prescribed, they provide towering efficacy for patients seeking reliable cardiac symptom management.

Supply and Trade: Seamless Global Distribution

With efficient export-quality packaging, Trimetazidine Hydrochloride Modified Release Tablets are available for global delivery from India's major ports, ensuring express shipping. Supply ability is robust and scalable, accommodating both bulk and tailor-suited orders. Upon purchase order confirmation, quotations for competitive rates are swiftly provided, with flexible payment terms for international clients-enabling a smooth procurement process for suppliers and traders worldwide.

FAQ's of Trimetazidine Hydrochloridde Modified Release Tablets:

Q: How should Trimetazidine Hydrochloride Modified Release Tablets be taken for best results?

A: For optimal benefit, the tablets should be administered orally with sufficient water, exactly as prescribed by your physician, commonly 35 mg twice daily. Adhering strictly to medical advice ensures maximum therapeutic efficacy.

Q: What are the main advantages of using these modified release tablets?

A: These tablets offer stable, controlled medication release for sustained anti-anginal effect, reduce frequency of chest pain episodes, and improve heart energy efficiency, all while providing convenience in dosing.

Q: When should a patient avoid taking Trimetazidine Hydrochloride Tablets?

A: This medication is contraindicated in individuals with severe renal impairment, Parkinson's disease, or hypersensitivity to the drug. Always consult a healthcare provider for assessment of suitability.

Q: Where are these tablets manufactured and what standards do they meet?

A: Trimetazidine Hydrochloride tablets are manufactured in India in a facility compliant with WHO-GMP certification, guaranteeing high global standards of quality and safety.

Q: What is the process for bulk purchasing and shipment?

A: Bulk orders are initiated through a formal purchase order. Once confirmed, a quotation is issued. Express shipping options are available from major Indian ports, with supply ability aligned to client needs and payment terms structured for international trade.

Q: What are some possible side effects of this medication?

A: Possible side effects include nausea, vomiting, abdominal pain, dizziness, or headache. For detailed information, users should refer to the leaflet enclosed with the packaging and consult a doctor if symptoms persist.

Tell us about your requirement